REFERENCES
1. Mankad P, Mitchell B, Birnie D, Kron J. Cardiac Sarcoidosis.Curr Cardiol Rep . 2019;21(12):152. doi:10.1007/s11886-019-1238-1.
2. Vignaux O, Dhote R, Duboc D, Blanche P, Devaux JY, Weber S, Legmann P. Detection of myocardial involvement in patients with sarcoidosis applying T2-weighted, contrast-enhanced, and cine magnetic resonance imaging: Initial results of a prospective study. J Comput Assist Tomogr . 2002;26(5):762-767. doi:10.1097/00004728-200209000-00017.
3. Silverman KJ, Hutchins GM, Bulkley BH. Cardiac sarcoid: A clinicopathologic study of 84 unselected patients with systemic sarcoidosis. Circulation . 1978;58(6):1204-1211. doi:10.1161/01.CIR.58.6.1204.
4. Ramirez R, Trivieri M, Fayad ZA, Ahmadi A, Narula J, Argulian E. Advanced imaging in cardiac sarcoidosis. J Nucl Med . 2019;60(7):892-898. doi:10.2967/jnumed.119.228130.
5. Birnie DH, Sauer WH, Bogun F, Cooper JM, Culver DA, Duvernoy CS, Judson MA, Kron J, Mehta D, Cosedis Nielsen J, Patel AR, Ohe T, Raatikainen P, Soejima K. HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis. Heart Rhythm . 2014;11(7):1304-1323. doi:10.1016/j.hrthm.2014.03.043.
6. Morimoto T, Azuma A, Abe S, Usuki J, Kudoh S, Sugisaki K, Oritsu M, Nukiwa T. Epidemiology of sarcoidosis in Japan. Eur Respir J . 2008;31(2):372-379. doi:10.1183/09031936.00075307.
7. Sharma A, Okada DR, Yacoub H, Chrispin J, Bokhari S. Diagnosis of cardiac sarcoidosis: an era of paradigm shift. Ann Nucl Med . 2020;34(2):87-93. doi:10.1007/s12149-019-01431-z.
8. Neto MLR, Jellis CL, Joyce E, Callahan TD, Hachamovitch R, Culver DA. Update in Cardiac Sarcoidosis. Ann Am Thorac Soc . 2019;16(11):1341-1350. doi:10.1513/AnnalsATS.201902-119CME.
9. Kouranos V, Tzelepis GE, Rapti A, Mavrogeni S, Aggeli K, Douskou M, Prasad S, Koulouris N, Sfikakis P, Wells A, Gialafos E. Complementary Role of CMR to Conventional Screening in the Diagnosis and Prognosis of Cardiac Sarcoidosis. JACC Cardiovasc Imaging . 2017;10(12):1437-1447. doi:10.1016/j.jcmg.2016.11.019.
10. Schouver ED, Moceri P, Doyen D, Tieulie N, Queyrel V, Baudouy D, Cerboni P, Gibelin P, Leroy S, Fuzibet JG, Ferrari E. Early detection of cardiac involvement in sarcoidosis with 2-dimensional speckle-tracking echocardiography. Int J Cardiol . 2017;227:711-716. doi:10.1016/j.ijcard.2016.10.073.
11. Voigt JU, Pedrizzetti G, Lysyansky P, Marwick TH, Houle H, Baumann R, Pedri S, Ito Y, Abe Y, Metz S, Song JH, Hamilton J, Sengupta PP, Kolias TJ, D’Hooge J, Aurigemma GP, Thomas JD, Badano LP. Definitions for a common standard for 2D speckle tracking echocardiography: Consensus document of the EACVI/ASE/industry task force to standardize deformation imaging. J Am Soc Echocardiogr . 2015;28(2):183-193. doi:10.1016/j.echo.2014.11.003.
12. Moharram MA, Lamberts RR, Whalley G, Williams MJA, Coffey S. Myocardial tissue characterisation using echocardiographic deformation imaging. Cardiovasc Ultrasound . 2019;17(1). doi:10.1186/s12947-019-0176-9.
13. Moher D, Liberati A, Tetzlaff J, Altman DG, Group TP. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. PLoS Med . 2009;6(7):e1000097. doi:10.1371/journal.pmed.1000097.
14. Lo CKL, Mertz D, Loeb M. Newcastle-Ottawa Scale: Comparing reviewers’ to authors’ assessments. BMC Med Res Methodol . 2014;14(1):45. doi:10.1186/1471-2288-14-45.
15. Aggeli C, Felekos I, Tousoulis D, Gialafos E, Rapti A, Stefanadis C. Myocardial mechanics for the early detection of cardiac sarcoidosis.Int J Cardiol . 2013;168(5):4820-4821. doi:10.1016/j.ijcard.2013.07.010.
16. Tigen K, Sunbul M, Karaahmet T, Tasar O, Dundar C, Yalcinsoy M, Takir M, Akkaya E. Early Detection of Bi-ventricular and Atrial Mechanical Dysfunction Using Two-Dimensional Speckle Tracking Echocardiography in Patients with Sarcoidosis. Lung . 2015;193(5):669-675. doi:10.1007/s00408-015-9748-0.
17. Kul S, Ozcelik HK, Uyarel H, Karakus G, Guvenc TS, Yalcinsoy M, Asoglu E, Kemik AS, Tasal A, Gungor S, Karaarslan E, Kart L, Goktekin O. Diagnostic value of strain echocardiography, galectin-3, and tenascin-C levels for the identification of patients with pulmonary and cardiac sarcoidosis. Lung . 2014;192(4):533-542. doi:10.1007/s00408-014-9586-5.
18. Kusunose K, Fujiwara M, Yamada H, Nishio S, Saijo Y, Yamada N, Hirata Y, Torii Y, Ise T, Yamaguchi K, Fukuda D, Yagi S, Soeki T, Wakatsuki T, Sata M. Deterioration of biventricular strain is an early marker of cardiac involvement in confirmed sarcoidosis. Eur Hear J - Cardiovasc Imaging . 2019;81:1-9. doi:10.1093/ehjci/jez235.
19. Bayat F, Fahimi A, Tavana S, Tabary M, Khaheshi I. Subclinical involvement of the heart and its associated factors in patients with sarcoidosis with normal systolic function using 2D speckle tracking.Echocardiography . 2020;37(1):41-46. doi:10.1111/echo.14572.
20. Joyce E, Ninaber MK, Katsanos S, Debonnaire P, Kamperidis V, Bax JJ, Taube C, Delgado V, Marsan NA. Subclinical left ventricular dysfunction by echocardiographic speckle-tracking strain analysis relates to outcome in sarcoidosis. Eur J Heart Fail . 2015;17(1):51-62. doi:10.1002/ejhf.205.
21. Felekos I, Aggeli C, Gialafos E, Kouranos V, Rapti A, Sfikakis P, Koulouris N, Tousoulis D. Global longitudinal strain and long-term outcomes in asymptomatic extracardiac sarcoid patients with no apparent cardiovascular disease. Echocardiography . 2018;35(6):804-808. doi:10.1111/echo.13846.
22. Değirmenci H, Demirelli S, Arısoy A, Ermiş E, Araz Ö, Bakırcı EM, Hamur H, Büyüklü M, Topal E. Myocardial deformation and total atrial conduction time in the prediction of cardiac involvement in patients with pulmonary sarcoidosis. Clin Respir J . 2017;11(1):68-77. doi:10.1111/crj.12307.
23. Murtagh G, Laffin LJ, Patel K V., Patel A V., Bonham CA, Yu Z, Addetia K, El-Hangouche N, Maffesanti F, Mor-Avi V, Hogarth DK, Sweiss NJ, Beshai JF, Lang RM, Patel AR. Improved detection of myocardial damage in sarcoidosis using longitudinal strain in patients with preserved left ventricular ejection fraction. Echocardiography . 2016;33(9):1344-1352. doi:10.1111/echo.13281.
24. Chiu CZ, Nakatani S, Zhang G, Tachibana T, Ohmori F, Yamagishi M, Kitakaze M, Tomoike H, Miyatake K. Prevention of left ventricular remodeling by long-term corticosteroid therapy in patients with cardiac sarcoidosis. Am J Cardiol . 2005;95(1):143-146. doi:10.1016/j.amjcard.2004.08.083.
25. Sengupta PP, Korinek J, Belohlavek M, Narula J, Vannan MA, Jahangir A, Khandheria BK. Left Ventricular Structure and Function. Basic Science for Cardiac Imaging. J Am Coll Cardiol . 2006;48(10):1988-2001. doi:10.1016/j.jacc.2006.08.030.
26. MM K, PM P, H A, G C, S W, AJ T, BK K, PP S. Relationship of Contrast-Enhanced Magnetic Resonance Imaging-Derived Intramural Scar Distribution and Speckle Tracking Echocardiography-Derived Left Ventricular Two-Dimensional Strains. Eur Heart J Cardiovasc Imaging . 2012;13(2). doi:10.1093/EJECHOCARD/JER163.
27. Orii M, Hirata K, Tanimoto T, Shiono Y, Shimamura K, Yamano T, Ino Y, Yamaguchi T, Kubo T, Tanaka A, Imanishi T, Akasaka T. Myocardial damage detected by two-dimensional speckle-tracking echocardiography in patients with extracardiac sarcoidosis: Comparison with magnetic resonance imaging. J Am Soc Echocardiogr . 2015;28(6):683-691. doi:10.1016/j.echo.2015.02.018.
28. Kim RJ, Patel MR, Cawley PJ, Heitner JF, Klem I, Parker MA, Jaroudi WA, Meine TJ, White JB, Elliott MD, Kim HW, Judd RM. Detection of myocardial damage in patients with sarcoidosis. Circulation . 2009;120(20):1969-1977. doi:10.1161/CIRCULATIONAHA.109.851352.
29. Chen, J., Lei, J., Scalzetti, E., McGrath, M., Feiglin, D., Voelker, R., Wang, J., Iannuzzi, M. C., & Liu, K. (2018). Myocardial contractile patterns predict future cardiac events in sarcoidosis. The international journal of cardiovascular imaging, 34(2), 251–262. https://doi.org/10.1007/s10554-017-1233-9